Medical Design & Outsourcing Launched Innovation Board
The 17-member board will provide strategic insights for medical device and technology executives.
Updated on Oct. 1, 2026 in Healthcare
Live Poll
Do you believe industry-led expert boards effectively improve the quality of new medical devices?
Medical Design & Outsourcing has established the Medtech Innovation Board to facilitate collaboration across the medical device sector. The board consists of 17 founding members with leadership experience at major industry players.
Why it matters
The board aims to address innovation challenges and foster industry-wide success by aggregating the expertise of seasoned professionals. Its output will serve as a resource for operators seeking to navigate complex R&D and market growth hurdles.
The new Medtech Innovation Board features 17 founding members drawing on expertise from established firms. While the composition is set, the impact of their shared insights on broader industry innovation cycles remains to be determined.
The players
Medtronic
A global leader in medical technology, services, and solutions that develops devices for chronic diseases.
Boston Scientific
A multinational manufacturer of medical devices used in interventional medical specialties.
Abbott
A diverse medical device and healthcare company with a broad portfolio of diagnostic and cardiovascular products.
Edwards Lifesciences
A global specialist in patient-focused medical innovations for structural heart disease and critical care monitoring.
Medical Design & Outsourcing
An industry publication and media platform focused on the engineering, manufacturing, and business of medical devices.
The details
The board convenes leaders from major medical device organizations to conduct private strategy sessions on R&D and leadership. These meetings are intended to identify recurring innovation bottlenecks and market opportunities, which will then be synthesized for broader distribution to the medical technology community. By sharing these success stories and trends, the group aims to provide actionable intelligence for companies operating in the medical device manufacturing space.
Timeline
October 1, 2026: The Medtech Innovation Board officially launched.
Market Landscape
The formation of the Medtech Innovation Board follows the industry's trend of utilizing peer-led consortia to standardize R&D approaches. This initiative mirrors similar efforts to aggregate expert intelligence in highly regulated sectors where technical innovation speed is a key competitive driver.
Operators should monitor upcoming public reports from the board for insights into R&D strategies and industry benchmarks. These findings may highlight new operational standards or shifts in innovation priorities that will affect medium-term development cycles.
The takeaway
Innovation boards are increasingly common vehicles for translating high-level industry expertise into practical development advice. Operators should treat the board's upcoming public findings as an industry signal for shifting R&D focus areas and emerging market risks.
Further reading
For more updates on technological shifts in the sector, visit the Healthcare section.
Source note: This article includes information reported by MassDevice.
Live Poll
Do you believe industry-led expert boards effectively improve the quality of new medical devices?
